CD274 and non-small cell lung carcinoma: A recent study has constructed deep learning model to predict PD-L1 expression (≥50%) with high performance (area under the receiver operating characteristic curve, AUC ≥0.71), which could help to predict the efficacy of immunotherapy in patients with NSCLC and indicate a direction for molecular prediction utilizing deep learning (15).